By LabPulse.com staff writers

October 9, 2019 -- Beckman Coulter's DxA 5000 lab automation system has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and is now available.

The company announced the FDA clearance and the system's availability in the U.S. on October 9, following a decision by the FDA on October 4. Beckman Coulter had showcased the DxA 5000 system, along with other workflow solutions for improving throughput in labs, at the American Association for Clinical Chemistry annual meeting in August and announced its approvals in Europe and China in May.

DxA 5000 lab automation system
The DxA 5000 lab automation system. Image courtesy of Beckman Coulter.

The DxA 5000 is being pitched as a system for labs of all sizes. According to the company, it reduces the number of manual steps required to process patient samples from 32 to four and intelligently routes specimens in accordance with capacity.

Beckman Coulter launches automation tools at AACC 2019
Beckman Coulter launched a new line of automation software at the 2019 American Association for Clinical Chemistry (AACC) meeting designed to help clinical...
FDA announces Beckman Coulter recall of hematology analyzers
Beckman Coulter Life Sciences has recalled several of its hematology analyzers due to the risk of inaccurate results, according to a U.S. Food and Drug...
Beckman Coulter gets DxA 5000 approvals
Beckman Coulter announced that its DxA 5000 lab automation system has received regulatory approvals in Europe and China.
Kalorama's notable product launches for clinical labs in Q1 2019
What were some of the most notable new product launches for clinical laboratories in the first quarter of 2019? Bruce Carlson of market research firm...
Beckman Coulter gets FDA nod for early sepsis test
Beckman Coulter has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Early Sepsis Indicator, a hematology-based cellular...

Copyright © 2019 LabPulse.com

Last Updated np 10/9/2019 11:48:11 AM



Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.
Email